Lenvatinib plus Pembrolizumab Combined with Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma

Bibliographic Details
Main Author:	Masatoshi Kudo
Format:	Article
Language:	English
Published:	Karger Publishers 2025-01-01
Series:	Liver Cancer
Online Access:	https://karger.com/article/doi/10.1159/000543245
Tags:	Add Tag No Tags, Be the first to tag this record!

Efficacy and Safety of Lenvatinib Plus Programmed Death-1 Inhibitors with or Without Transarterial Chemoembolization in the Treatment of Unresectable Hepatocellular Carcinoma
by: Jin M, et al.
Published: (2024-11-01)

Effectiveness of sorafenib in treating intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization
by: Reham Ashour, et al.
Published: (2024-11-01)

Efficacy and Safety of Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib for Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven: A Multicentre, Retrospective Propensity Score Matching Analysis
by: Zhong S, et al.
Published: (2025-03-01)

Sintilimab plus lenvatinib in combination with transarterial chemoembolization and subsequent radiofrequency ablation for unresectable hepatocellular carcinoma: a single-arm, single-center study
by: Xiaochun Chen, et al.
Published: (2025-07-01)

Efficacy and safety of lenvatinib plus transarterial chemoembolization with or without programmed death-1 inhibitors in the treatment of intermediate or advanced hepatocellular carcinoma: a systematic review and meta-analysis
by: Yongfa Lei, et al.
Published: (2025-07-01)

Immune Checkpoint Inhibitor plus Anti-VEGF/TKI Combined with Transarterial Chemoembolization in Locally Advanced Nonmetastatic Hepatocellular Carcinoma: Real-World Treatment Strategy Based on Phase 3 Clinical Trial Results
by: Masatoshi Kudo
Published: (2025-01-01)

Idarubicin-loaded drug-eluting microspheres transarterial chemoembolization for intermediate stage hepatocellular carcinoma: safety, efficacy, and pharmacokinetics
by: Korsic Spela, et al.
Published: (2024-10-01)

Transarterial Chemoembolization Plus Camrelizumab and Rivoceranib versus Camrelizumab and Rivoceranib Alone for BCLC Stage C Hepatocellular Carcinoma
by: Zhou WJ, et al.
Published: (2024-12-01)

The Synergistic Mechanisms and Prospects of Transarterial Chemoembolization Combined with Immunotherapy for Hepatocellular Carcinoma
by: Chen QF, et al.
Published: (2025-04-01)

Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: Predictors of Survival
by: Summit Sawhney, et al.
Published: (2011-01-01)

Transarterial chemoembolization with insertion of radioactive seeds for hepatocellular carcinoma
by: You-Bin Wang, et al.
Published: (2023-09-01)

Real-world outcomes of lenvatinib plus pembrolizumab in intermediate- and poor-risk metastatic renal cell carcinoma
by: Ilya Tsimafeyeu, et al.
Published: (2025-04-01)

Conventional transarterial chemoembolization followed by irreversible electroporation for hepatocellular carcinoma
by: Meng Zhao, et al.
Published: (2025-02-01)

Development and validation of a prealbumin–bilirubin model for prognostic prediction in intermediate hepatocellular carcinoma undergoing transarterial chemoembolization
by: Nan Jiang, et al.
Published: (2025-05-01)

Safety and efficacy of PD-1 inhibitor (sintilimab) combined with transarterial chemoembolization as the initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria
by: Lei Yu, et al.
Published: (2025-01-01)

The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma
by: Zhentian Xu, et al.
Published: (2019-01-01)

Balloon-occluded versus conventional transarterial chemoembolization for the treatment of early to intermediate stage hepatocellular carcinoma: a meta-analysis and trial sequential analysis
by: Jiaxi Liu, et al.
Published: (2025-07-01)

Combination Therapy of Transarterial Chemoembolization, Lenvatinib, and PD-1 Inhibitors Achieves Significant Tumor Response in Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Case Report
by: Fu Y, et al.
Published: (2025-04-01)

Transarterial radioembolization versus chemoembolization for hepatocellular carcinoma: a meta-analysis
by: Wenxiao Lu, et al.
Published: (2025-01-01)

Transarterial chemoembolization in hepatocellular carcinoma treatment during the COVID-19 pandemic
by: Filipović Aleksandar, et al.
Published: (2024-01-01)

Multicenter Study on Transarterial Chemoembolization Combined with Radiofrequency Ablation for Early-Stage Hepatocellular Carcinoma: Primary versus Recurrent HCC
by: Chen YT, et al.
Published: (2024-12-01)

Transarterial chemoembolization plus apatinib for unresectable hepatocellular carcinoma: a multicenter, randomized, open-label, phase III trial
by: Xue-Feng Kan, et al.
Published: (2025-05-01)

Letter to the editor: safety and efficacy of PD-1 inhibitor (sintilimab) combined with transarterial chemoembolization as the initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria
by: Bi-Cheng Wang
Published: (2025-03-01)

Combined radiofrequency ablation or microwave ablation with transarterial chemoembolization can increase efficiency in intermediate-stage hepatocellular carcinoma without more complication: a systematic review and meta-analysis
by: Yao Yang, et al.
Published: (2022-12-01)

Pembrolizumab Plus Lenvatinib for Metastatic Renal Cell Carcinoma in a Patient on Hemodialysis
by: Shimpei Yamashita, et al.
Published: (2025-05-01)

TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma
by: Wang W, et al.
Published: (2025-01-01)

Obstructive Jaundice Following Transarterial Chemoembolization for Hepatocellular Carcinoma with Bile Duct Invasion
by: Kazuki Matsushita, et al.
Published: (2021-06-01)

Transarterial Chemoembolization for Patients With Hepatocellular Carcinoma Using Miriplatin Without the Need for Hydration
by: Koji Fujita, et al.
Published: (2025-03-01)

Rupture of Hepatocellular Carcinoma after Transarterial Chemoembolization followed by Massive Gastric Bleeding
by: Kazuhiro Nishida, et al.
Published: (2018-01-01)

Predicting Response to Transarterial Chemoembolization in Hepatocellular Carcinoma Using Machine Learning Models
by: Niharika Dutta, et al.

Transarterial chemoembolization and early arterial complications after liver transplantation for hepatocellular carcinoma
by: V. V. Borovik, et al.
Published: (2022-09-01)

Possible applications for combined lenvatinib and pembrolizumab in advanced endometrial carcinoma
by: K. V. Menshikov, et al.
Published: (2023-01-01)

Quantitative literature analysis on efficacy and safety of balloon-occluded transarterial chemoembolization for hepatocellular carcinoma
by: Wei Fan Sui, et al.
Published: (2025-06-01)

Efficacy of cone-beam computed tomography and guidance software in transarterial chemoembolization for hepatocellular carcinoma
by: Shiro Miyayama
Published: (2025-06-01)

Evaluation of different scoring systems for repeating Transarterial Chemoembolization in Egyptian patients with Hepatocellular Carcinoma
by: Alhaddad Omkolsoum, et al.
Published: (2024-12-01)

Peripheral T lymphocyte immune characteristics dictate response to transarterial chemoembolization in unresectable hepatocellular carcinoma
by: Lei Peng, et al.
Published: (2025-05-01)

Impact of frailty on the long-term prognosis of the elderly with hepatocellular carcinoma treated with transarterial chemoembolization
by: Yu-Fei Shao, et al.
Published: (2025-04-01)

Effects of Oral L-Carnitine on Liver Functions after Transarterial Chemoembolization in Intermediate-Stage HCC Patients
by: Abeer Hassan, et al.
Published: (2015-01-01)

The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection.
by: Seong Kyun Na, et al.
Published: (2018-01-01)

The efficacy of transarterial chemoembolization combined with helical iodine-125 seed implant, lenvatinib and PD-1 inhibitors in patients with hepatocellular carcinoma complicated by main portal vein tumor thrombus: a retrospective study
by: Jia-Wen Lin, et al.
Published: (2025-05-01)

Lenvatinib plus Pembrolizumab Combined with Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma

Similar Items

Similar Items